AAAAAA
Results: 1-25/31
Authors:
Hammerschlag, MR
Citation: Mr. Hammerschlag, Use of nucleic acid amplification tests in investigating child sexual abuse, SEX TRANS I, 77(3), 2001, pp. 153-154
Authors:
Dowell, SF
Peeling, RW
Boman, J
Carlone, GM
Fields, BS
Guarner, J
Hammerschlag, MR
Jackson, LA
Kuo, CC
Maass, M
Messmer, TO
Talkington, DF
Tondella, ML
Zaki, SR
Bandea, C
Black, C
O'Conner, S
Papp, J
Perilla, MJ
Schuchat, A
Stevens, V
Van Beneden, CA
Zell, ER
Cohen, C
Campbell, LA
Wwang, SP
Grayston, JT
Deal, CD
Gaydos, C
Schindler, L
Taylor, CE
Mahony, J
Fong, IW
Leinonen, M
Saikku, P
Maas, M
Ossewaarde, JM
Persson, K
Boman, J
Apfalter, P
Citation: Sf. Dowell et al., Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada), CLIN INF D, 33(4), 2001, pp. 492-502
Authors:
Hammerschlag, MR
Citation: Mr. Hammerschlag, Mycoplasma pneumoniae infections, CURR OPIN I, 14(2), 2001, pp. 181-186
Authors:
Hammerschlag, MR
Boman, J
Rowley, AH
Citation: Mr. Hammerschlag et al., Failure to demonstrate Chlamydia pneumoniae in cardiovascular tissue from children with Kawaski disease, PEDIAT INF, 20(1), 2001, pp. 76-77
Authors:
Hammerschlag, MR
Citation: Mr. Hammerschlag, Efficacy and safety of gemifloxacin in the treatment of community-acquiredpneumonia: a randomized, double-blind comparison with trovafloxacin, J ANTIMICRO, 48(5), 2001, pp. 735-735
Authors:
Hammerschlag, MR
Roblin, PM
Bebear, CM
Citation: Mr. Hammerschlag et al., Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens, J ANTIMICRO, 48, 2001, pp. 25-31
Authors:
Kutlin, A
Flegg, C
Stenzel, D
Reznik, T
Roblin, PM
Mathews, S
Timms, P
Hammerschlag, MR
Citation: A. Kutlin et al., Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model, J CLIN MICR, 39(10), 2001, pp. 3721-3723
Authors:
Boman, J
Sundstrom, P
Roblin, PM
Hammerschlag, MR
Citation: J. Boman et al., Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS - Reply, NEUROLOGY, 57(4), 2001, pp. 746-746
Authors:
Hirshkowitz, M
Sharafkhaneh, A
Hammerschlag, MR
Citation: M. Hirshkowitz et al., Asymptomatic respiratory infection with Chlamydia pneumoniae - What does it mean?, CHEST, 119(5), 2001, pp. 1303-1305
Authors:
Roblin, PM
Hammerschlag, MR
Citation: Pm. Roblin et Mr. Hammerschlag, In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis, INT J ANT A, 16(1), 2000, pp. 61-63
Authors:
Hammerschlag, MR
Citation: Mr. Hammerschlag, Treatment of Chlamydia pneumoniae, INT J ANT A, 15(3), 2000, pp. 239-239
Authors:
Hammerschlag, MR
Roblin, PM
Citation: Mr. Hammerschlag et Pm. Roblin, Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumonias, INT J ANT A, 15(2), 2000, pp. 149-152
Authors:
Hammerschlag, MR
Citation: Mr. Hammerschlag, Chlamydia pneumoniae and the lung, EUR RESP J, 16(5), 2000, pp. 1001-1007
Authors:
Hammerschlag, MR
Citation: Mr. Hammerschlag, Chlamydia pneumoniae and atherosclerosis: What we know and what we don't know, PEDIAT INF, 19(1), 2000, pp. 75-76
Authors:
Ke, Z
Lu, FM
Roblin, P
Boman, J
Hammerschlag, MR
Kalman, B
Citation: Z. Ke et al., Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis, ANN NEUROL, 48(3), 2000, pp. 400-400
Authors:
Hammerschlag, MR
Citation: Mr. Hammerschlag, Activity of gemifloxacin and other new quinolones against Chlamydia pneumoniae: a review, J ANTIMICRO, 45, 2000, pp. 35-39
Authors:
Hammerschlag, MR
Ke, Z
Lu, FM
Roblin, P
Boman, J
Kalman, B
Citation: Mr. Hammerschlag et al., Is Chlamydia pneumoniae present in brain lesions of patients with multiplesclerosis?, J CLIN MICR, 38(11), 2000, pp. 4274-4276
Authors:
Hammerschlag, MR
Roblin, PM
Citation: Mr. Hammerschlag et Pm. Roblin, Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae, ANTIM AG CH, 44(5), 2000, pp. 1409-1409
Authors:
Strigl, S
Roblin, PM
Reznik, T
Hammerschlag, MR
Citation: S. Strigl et al., In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydiapneumoniae, ANTIM AG CH, 44(4), 2000, pp. 1112-1113
Authors:
Boman, J
Sundstrom, P
Roblin, PM
Hammerschlag, MR
Citation: J. Boman et al., Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS - Reply from the authors, NEUROLOGY, 55(9), 2000, pp. 1423-1424
Authors:
Boman, J
Roblin, PM
Sundstrom, P
Sandstrom, M
Hammerschlag, MR
Citation: J. Boman et al., Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS, NEUROLOGY, 54(1), 2000, pp. 265-265
Authors:
Strigl, S
Kutlin, A
Roblin, PM
Shulman, S
Hammerschlag, MR
Citation: S. Strigl et al., Is there an association between Kawasaki disease and Chlamydia pneumoniae?, J INFEC DIS, 181(6), 2000, pp. 2103-2105
Authors:
Hammerschlag, MR
Citation: Mr. Hammerschlag, New diagnostic methods for chlamydial infection in women, MEDSC W H, 4(5), 1999, pp. NIL_3-NIL_10
Authors:
Hammerschlag, MR
Citation: Mr. Hammerschlag, Community-acquired pneumonia due to atypical organisms in adults: Diagnosis and treatment, INF DIS C P, 8(5), 1999, pp. 232-240
Authors:
Roblin, PM
Kutlin, A
Reznik, T
Hammerschlag, MR
Citation: Pm. Roblin et al., Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae, INT J ANT A, 12(2), 1999, pp. 181-184